Choose Location

24-04-2019 (Singapore)

P40091 Pharma Pricing – Commercial and Regulatory Strategies
Download Brochure Request

Register your interest


Register your interest


Pharma Pricing – Commercial and Regulatory Strategies

24-25 April, 2019, Singapore

Book Now Download Brochure



Key Learning Outcomes

  • Pharma pricing strategies and case studies across product segments – biosimilars, generics, combinations, brands, OTC, orphans in ASEAN
  • Price control mechanisms and tools
  • Who sets the pricing and what influences them
  • The growing importance of “value for money” considerations
  • Understanding how healthcare structures and models impact pricing
  • Pharma reimbursement strategies
  • Pharma pricing composition and sensitivity

Who Should Attend

  • People in domestic marketing who want to learn about other markets
  • People in regulatory who want to learn about commercial issues
  • Strategic planners who want to know where they might go next
  • Those who want insight into the way that markets influence each other
  • Anyone who wants to understand global pricing issues


Packages Price
2 Day TrainingSGD $3495SGD $3095Early BirdEarly Bird

Super Early Bird Rate: SGD 3,095 (SGD 400 off normal rates)
Register and Pay on or before 31 December 2018

Register 2 Delegates & the 3rd attends FREE!
Group rate is based on normal rate of 2-day training package only.
For Group Registrations, email or call +65 6508 2401


  • Special Group Discount pricing is applicable to groups of 2 or more delegates from the same organisation registering for the same event, at the same time.
  • Fee stated is the discounted price PER DELEGATE. Only one discount applies – either the early bird rate OR the Special Group Discount.
  • All fees stated include luncheons, refreshments and complete set of documentation. It does not include the cost of accommodation and travel.
  • A 7% Goods & Services Tax (GST) is applicable to all Singapore based companies for Singapore venue.
  • View payment terms and bank transfer details, click here »


“Exercises were useful and trainer is knowledgeable”
– Noor Aida Binti Jaafar, Head of Marketing & Specialty Care, CCM Pharmaceutical

“Case Studies and the workshop activities really helped a lot and more practical”
– Praveen Kumar, Senior Manager, Pharmaniaga

“Informative & insightful. Had a chance to network and share discussion / cross learn from participants”
– Chng Kien Peng, Executive Director, Xepa-Soul Pattinson (S) Pte Ltd

“The course is very relevant to my job. The case studies and the workshop activities really helped a lot and were practical.
– Avadhanula Yagna Praveen Kumar, Senior Manager Intellectual Property, Pharmaniaga BHD

“Very informative. It covers all scopes under the topics”
– Norliza Binti Abdullah Zawawi, Legal Assistant Manager, Pharmaniaga Berhad


Frans G van Andel, MSc, MPH, PhD


A comprehensive approach to funding: pricing, reimbursement and procurement of medicines in a global and Asian perspective.

The International P&R Environment

Session 1 – Healthcare structures and models

  • USA example
  • European example
  • ASEAN example

Session 2 – Country cost control measures (demand and supply approaches)

  • USA example
  • European example
  • ASEAN example

Session 3 – Pricing and reimbursement systems across the globe

  • USA example
  • European example
  • ASEAN example

Strategy: Pricing & Reimbursement Strategy

Session 4 – Price composition and sensitivity

  • Price modelling
  • Secondary research
  • Primary research
  • Scientific advice (P&R and regulatory)
  • Competitive response
  • International aspects

Session 5 – Reimbursement

  • Requirements
  • Preparing dossiers
  • Negotiations
  • International aspects

Session 6: Proving value

  • Informing clinical strategy
  • HTA overview
  • HTA applications and case studies
  • Demonstrating value to payers and regulators
  • Early market access approach
  • In-licensing due diligence

Session 7: Formulary management – ASEAN case study

  • Rational selection of products methodology
  • How drug selection works at national, regional and hospital level
  • Procurement models and consortia
  • Final negotiations
  • International aspects

Case Study and Discussion:

  • Strategic Pharma Pricing Roadmap
  • ASEAN’s response to “Early Market Access”

Session 8: Market access in relation to pricing, reimbursement and procurement

  • Early access schemes
  • Reference pricing, price corridors and launch sequencing
  • Indication sequencing
  • Patient access schemes
  • Parallel trade

Market Access across Product Categories in ASEAN

Session 9 – Orphan Drugs Module

  • Introduction
  • Specific considerations
  • Regulations supporting access
  • Pricing
  • Pre-approval use
  • Case studies and lessons learned – Rare diseases

Session 10 – Biosimilars and Pricing

  • Clinical and Budget impact data needs
  • Pricing and reimbursement requirements
  • Operational issues

Session 11 – Combination products

  • Position of regulators
  • Pricing and reimbursement requirements
  • Data needs and studies

Session 12: Generics

  • Abbreviated pricing and reimbursement procedures
  • Data needs and studies
  • Limits in pricing and reimbursement

when & where

24 - 25 Apr 2019

On-site & in-house training

Deliver this course how you want, where you want, when you want – and save up to 40%! 8+ employees seeking training on the same topic?

Talk to us about an on-site/in-house & customised solution.


IBC Asia is Singapore's leading event organiser. We conceive, develop and promote our own B2B industry conferences and corporate training courses, and offer tailored managed event solutions.

Find out more